to Content
Header Image Dorothee VON LAER Professorin und Leiterin, Sektion für Virologie, Department für Hygiene, Mikrobiologie, Sozialmedizin, Medizinische Universität Innsbruck; ONCOTYROL - Center for Personalized Cancer Medicine GmbH, Innsbruck


1978-1985 Medical School Hamburg, Germany
1985 Final medical exam: 'Staatsexamen' and Approbation
1985-1987 Thesis in Biochemistry
1987 Conferral of
1987-1988 Scientist at the 'Institut für Medizinische Mikrobiologie', Hamburg University
1988-1991 Physician and scientist at the 'Bernhard-Nocht-Institut für Tropenkrankheiten (tropical diseases)', Hamburg
1992-1996 Scientist at the 'Abteilung für Virologie, Institut für Med. Mikrobiologie & Hygiene' of the Albert Ludwig University of Freiburg, Germany
1994 Specialist (Facharzt) for Microbiology and Infectious Diseases
1996 Habilitation (venia legendi) at the Albert Ludwig University of Freiburg
1996-2000 Senior scientist at the 'Heinrich-Pette-Institut für Experimentelle Virologie' (a biomedical research institute), Hamburg University
2000-2009 Head of the section 'Applied Virology and Gene Therapy' at the Georg-Speyer-Haus, Frankfurt am Main
2003-2009 Full Professor of Applied Virology and Gene Therapy at the Goethe University Frankfurt, Medical School, Germany
since 2010 Full Professor for Virology and Head of the Division for Virology at the Medical University Innsbruck, Austria


Member, German Society of Virology and the German Society of Gene Therapy
Member, European Society for Cell and Gene Therapy
Member, American Society for Gene Therapy
Member, Austrian Society for Hygiene, Microbiology and Preventive Medicine


von Laer, D. et al: Normal brain cells contribute to the bystander effect in a suicide gene therapy - approach for malignant glioma using lentiviral pseudotyped vectors. Clin. Cancer Res. 13:6761-8, 2007
von Laer, D. et al: Resistance of mature T cells to oncogene transformation. Blood 112:2278-2286, 2008
von Laer, D. et al: Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy. PlosONE 4 (Jul20): 36314, 2009
von Laer, D. et al: Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism. J.Virol., 85(11): 5679-84, 2011


Wolfgang Stille Preis, 2008
Member of the Board, German Society of Virology
Member of the Board, German Society of Gene Therapy